Recombinant Comments : Analyzing the Public Response to Proposed rDna Products
Loading...
Files
Date
Authors
Mabis, Matthew
Advisors
License
DOI
Type
Presentation
Journal Title
Journal ISSN
Volume Title
Publisher
Grantor
Abstract
A significant issue in the public understanding of science is the way in which citizens use digital media to influence policy making on cutting-edge research and emerging technologies. This study examines the public comments on the Food and Drug Administration's proposed guidelines for ATryn, the first drug manufactured from nonbacterial recombinant DNA, that is, human-animal gene splicing.
Description
Color poster with text, charts, and graphs.
Related Material and Data
Citation
Sponsorship
University of Wisconsin--Eau Claire Office of Research and Sponsored Programs